Clinic Catalyst
AI contact center and operations platform for healthcare providers to automate patient interactions.
Website: https://cliniccatalyst.com/
Cover Block
From the public record
| Attribute | Details |
|---|---|
| Company Name | Clinic Catalyst |
| Tagline | AI contact center and operations platform for healthcare providers to automate patient interactions. |
| Headquarters | Los Angeles, North America |
| Founded | 2024 |
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Pre-seed |
| Total Disclosed Funding | Undisclosed [Crunchbase, May 2025] |
Links
From the public record
- Website: https://cliniccatalyst.com/
- LinkedIn: https://www.linkedin.com/in/siddharthkandarpshah
The Short Version
From the public record Clinic Catalyst is building an AI-powered contact center platform specifically for healthcare providers, a bet that the administrative burden of patient communication represents a large, addressable market for automation. The Los Angeles-based startup, founded in 2024, aims to become what it calls the 'AI backbone for healthcare ops' by automating inbound calls, patient outreach, appointment scheduling, and paperwork processing [HealthTech Alpha, January 2024].
The founding story centers on Siddharth Shah, a co-founder of India's online pharmacy giant PharmEasy, who brings a decade of healthcare and technology operating experience to the venture [TechCrunch, June 2021]. He is joined by co-founder Roshini Rajan, though her specific background is not detailed in public sources [F6S, October 2017]. The company's initial differentiation appears to be a focus on the full spectrum of front-office patient interactions, rather than clinical diagnostics or back-end record-keeping.
Clinic Catalyst closed a pre-seed round in May 2025, with Forum Ventures and Right Side Capital Management listed as investors, though the amount raised remains undisclosed [Crunchbase, May 2025]. It operates a SaaS business model targeting healthcare clinics. Over the next 12-18 months, the key watchpoints will be the transition from early platform development to named customer deployments, the validation of its claimed 80% call cost savings, and the articulation of a defensible moat against both general-purpose contact center AI and specialized healthtech competitors.
Single-source, plausible -- Core company description and funding investors confirmed by multiple directories and Crunchbase; founder's prior role at PharmEasy is well-documented. Key operational claims (customer savings, product capabilities) are sourced primarily from the company or unverified profiles.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Pre-seed |
The Company in Brief
From the public record
Clinic Catalyst was founded in 2024 by Siddharth Shah and Roshini Rajan, positioning itself as an AI contact center and operations platform for healthcare providers [HealthTech Alpha, January 2024]. The company is headquartered in Los Angeles, California, and operates as a pre-seed stage SaaS venture [Crunchbase, May 2025]. Its public positioning, described as the "AI backbone for healthcare ops," frames the company's mission around automating administrative workflows like patient calls and scheduling [cliniccatalyst.com, retrieved 2024].
The founding team's public profile is anchored by Siddharth Shah, identified as a founder of PharmEasy, a major Indian online pharmacy [Bloomberg, July 2021]. His professional record includes executive roles at API Holdings and Navikenz Inc., with a background spanning data, AI, and sales leadership [Bloomberg Markets, retrieved 2026]. Co-founder Roshini Rajan is listed alongside Shah, though her specific role and professional history are not detailed in public sources [F6S, October 2017].
A key early milestone was the closing of a pre-seed funding round in May 2025, led by Forum Ventures with participation from Right Side Capital Management [Crunchbase, May 2025]. The company's development timeline from founding to this initial institutional backing appears compressed, a pattern typical for ventures launched by founders with established industry networks.
Single-source, plausible -- Core company facts (founding year, HQ, founders, pre-seed round) are confirmed by Crunchbase and founder profiles. Some product positioning and team characterizations are sourced from company-controlled materials or unverified directories.
What They Have Built
Mixed sourcing
The company positions its core offering as an AI-powered operations layer for healthcare clinics, a system it describes as "the AI backbone for healthcare ops" [cliniccatalyst.com, retrieved 2024]. The platform's stated purpose is to automate the high-volume, repetitive administrative tasks that burden clinic staff, shifting the focus from manual coordination to patient care.
Publicly described capabilities center on patient communication and workflow automation. According to company profiles, the platform handles inbound patient calls, automated outreach for appointment reminders or follow-ups, appointment scheduling, and paperwork processing [HealthTech Alpha, January 2024]. These interactions are facilitated by what the company terms "AI agents," suggesting a conversational interface for patient communications [Crunchbase, retrieved 2024]. A primary claimed benefit for customers is cost reduction, with the company stating clinics save over 80% on call costs after switching to its system [cliniccatalyst.com, retrieved 2024].
The underlying technology stack is not detailed in public sources. The product's reliance on AI for natural language understanding and workflow automation can be inferred, but specific model choices, integration architecture, or data security protocols are not disclosed. There is no public announcement of a product roadmap, forthcoming features, or technical partnerships.
Single-source, plausible -- Core product claims are sourced from the company website and a single industry profile; the 80% cost-savings metric is company-only and unverified.
Market Size and Demand
From the public record The market for administrative automation in healthcare is expanding as provider margins compress and patient engagement expectations rise, creating a clear opening for AI-driven workflow tools. The specific opportunity for Clinic Catalyst sits at the intersection of two large, well-documented markets: the broader healthcare contact center software space and the targeted segment of AI-powered patient access and scheduling solutions.
Third-party sizing for the precise 'AI contact center for healthcare' niche is not publicly available. However, analogous market reports provide a sense of scale. The global healthcare contact center market was valued at approximately $1.6 billion in 2022 and is projected to grow at a compound annual rate of 17.8% through 2030, according to Grand View Research [Grand View Research, 2023]. The adjacent market for AI in healthcare administration, which includes scheduling, billing, and patient communication, is forecast to exceed $10 billion by 2027 [MarketsandMarkets, 2023]. Clinic Catalyst's serviceable obtainable market (SOM) would be a fraction of these totals, initially targeting independent clinics and small provider groups in North America before scaling to larger health systems.
Demand is driven by persistent operational pain points. Provider staffing shortages, particularly for administrative roles, increase the burden on clinical staff and degrade patient experience. Manual processes for scheduling, reminders, and intake paperwork are error-prone and contribute to no-show rates that can reach 30% in some outpatient settings [MGMA, 2022]. The company's cited claim that customers save over 80% on call costs after switching points directly to this cost pressure, though the claim originates from the company website [cliniccatalyst.com, retrieved 2024]. Regulatory tailwinds, such as value-based care models that penalize poor patient adherence and reward closed care gaps, further incentivize investment in patient engagement automation.
Key adjacent markets include general-purpose AI contact center software (e.g., vendors like Five9 or Talkdesk with healthcare modules) and clinical decision support AI (e.g., Aidoc for radiology). These represent both potential partners and competitive substitutes. A clinic might choose to extend its existing CRM or contact center platform with AI features rather than adopt a dedicated healthcare-specific solution. Macro forces, including tightening reimbursement rates and rising patient expectations for digital convenience, are likely to sustain budget allocation toward operational efficiency tools, though economic downturns could lengthen sales cycles for new software categories.
Healthcare Contact Center Market (2022) | 1.6 | $B
AI in Healthcare Admin Market (2027 Projection) | 10 | $B
The available sizing data, while not specific to Clinic Catalyst's product, indicates a large and growing addressable space for automation. The growth rates suggest investor and buyer appetite for solutions that can demonstrably reduce administrative overhead and improve patient throughput.
Who Else Is Fighting for This
Mixed sourcing Clinic Catalyst enters a crowded field of healthcare automation tools, positioning itself as a specialized AI contact center and operations platform for clinics, a wedge distinct from clinical decision support or general-purpose enterprise software.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Clinic Catalyst | AI contact center & ops platform for healthcare providers. | Pre-seed (2025). | Focus on automating patient interactions (calls, outreach, scheduling). | [HealthTech Alpha, January 2024]; [Crunchbase, May 2025] |
| Luminai | AI workflow automation for healthcare operations. | Seed (2023). | Emphasis on clinical and administrative workflow orchestration. | [Crunchbase] |
| Aidoc | AI for medical imaging analysis and clinical decision support. | Series C (2021). | Deep integration with radiology workflows and FDA-cleared algorithms. | [Crunchbase] |
| Hippocratic AI | Generative AI for non-diagnostic, patient-facing healthcare tasks. | Series A (2024). | Focus on safety-certified large language models for patient communication. | [Crunchbase] |
The competitive map breaks into three distinct layers. The first layer consists of large-scale, horizontal contact-center-as-a-service (CCaaS) platforms like Twilio and Five9. These are not healthcare-specific but are deeply embedded in enterprise IT stacks, offering robust telephony and basic CRM integrations that a new entrant must either replace or integrate with. The second layer includes healthcare-specific workflow and revenue cycle management incumbents, such as Epic and Athenahealth. Their dominance in electronic health records creates a formidable integration and data-access hurdle for any new operations layer. The third and most directly relevant layer is the emerging cohort of AI-native healthcare automation startups, where Clinic Catalyst, Luminai, and Hippocratic AI compete.
Within this AI-native cohort, Clinic Catalyst's stated edge is its narrow focus on the front-office patient interaction loop. This is a perishable advantage. It is defensible today only if the company can rapidly accumulate proprietary, clinic-specific conversation data and workflow patterns that generic LLMs or broader platforms cannot easily replicate. The durability of this edge depends on execution speed and capital to fund model training and sales efforts before larger players or better-funded specialists like Hippocratic AI decide to build or buy a similar module. The founders' healthcare background, particularly Siddharth Shah's experience with PharmEasy, suggests an understanding of provider operations, but this is a market-access advantage, not a technical moat.
Clinic Catalyst's most significant exposure is its lack of a protected channel or a must-have integration. A competitor like Luminai, which targets broader operational workflows, could expand into patient communications and use existing customer relationships. More critically, the company appears vulnerable to being sidelined by the EHR incumbents. If Epic or Athenahealth decides to bundle a basic AI scheduling and outreach module into their core platform,a logical extension of their patient portal strategies,it could eliminate the need for a standalone point solution like Clinic Catalyst before it achieves critical mass.
The most plausible 18-month scenario is one of fragmentation and feature competition. A winner will emerge if one company, likely the best-capitalized or the one with the sharpest product-market fit, can demonstrate clear, quantifiable ROI on labor cost reduction and patient satisfaction for a specific clinic segment, such as independent specialty practices. Clinic Catalyst could be that winner if it uses its pre-seed capital to lock in a dense network of early-adopter clinics in a defined geographic or vertical niche. A loser in this scenario would be any platform that remains a generic "AI for healthcare ops" without a clear, measurable use case that justifies its cost and implementation complexity. Without swift traction, Clinic Catalyst risks being categorized as a feature, not a platform, and becoming an acquisition target for a larger player seeking to fill a gap, rather than a standalone venture-scale business.
Single-source, plausible -- Competitor profiles are sourced from Crunchbase; Clinic Catalyst's positioning is from company profiles and a funding announcement. The competitive analysis and scenario are analytical inferences based on public market structure.
Opportunity
From the public record
If Clinic Catalyst can successfully automate the administrative core of small to mid-sized healthcare practices, the operational savings and workflow capture represent a multi-billion dollar addressable market in North America alone.
The headline opportunity is to become the default operational layer for outpatient care delivery, a category-defining platform that handles all non-clinical patient interactions. The cited evidence points to a wedge through cost reduction, with the company claiming its platform helps customers save over 80% on call costs [cliniccatalyst.com, retrieved 2024]. For a sector burdened by thin margins and administrative bloat, a proven tool that directly cuts a major expense line while improving patient access creates a compelling entry point. This positions Clinic Catalyst not as another point solution for scheduling, but as an integrated "AI backbone" that could gradually own the entire patient communication stack, from first contact to follow-up [HealthTech Alpha, January 2024]. The founder's background in scaling a massive healthcare logistics platform in PharmEasy provides a relevant, though not directly transferable, template for navigating complex provider workflows [Bloomberg, July 2021].
Growth from a niche automation tool to a platform of record depends on specific, plausible expansion paths. The following scenarios outline concrete routes to scale.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Vertical SaaS Dominance | Clinic Catalyst becomes the mandated patient operations system for a large, multi-location dental or dermatology practice chain. | A flagship enterprise contract with a 100+ location group, serving as a public case study. | The product's described scope (inbound calls, outreach, scheduling, paperwork) maps directly to the chronic administrative pain points of specialty clinics [HealthTech Alpha, January 2024]. A single large win in a concentrated vertical can create a repeatable sales playbook. |
| Embedded Insurance Workflow | The platform is adopted by payers or PBMs as a preferred tool for providers to automate prior authorizations and eligibility checks, becoming a gatekeeper for reimbursement data flow. | A partnership with a regional health plan to integrate its AI agents into the provider's pre-claim workflow. | Founder Siddharth Shah's prior role as Chief of Data & AI at Navikenz, a firm focused on AI-driven business transformation, suggests familiarity with integrating complex systems into enterprise processes [Bloomberg Markets, retrieved 2026]. The administrative burden of insurance paperwork is a universal and costly friction point. |
Compounding for Clinic Catalyst would likely manifest as a data and workflow lock-in effect, rather than a classic network effect. Each new clinical practice onboarded generates proprietary data on local patient communication patterns, preferred scheduling windows, and common administrative hurdles. This dataset could be used to continuously refine the AI agents' success rates and conversational flows, creating a product that becomes more tailored and effective for similar practices in the same region or specialty. Over time, as the platform manages more core operations, switching costs for the provider increase significantly. The platform's own description as an "AI backbone" implies this ambition of deep, systemic integration [PERPLEXITY SONAR PRO BRIEF, retrieved 2024].
The size of the win can be framed by looking at the valuation of public companies that provide essential, non-discretionary software to healthcare providers. For example, NextGen Healthcare, a provider of practice management and electronic health records software primarily for ambulatory care, was acquired for approximately $1.8 billion in 2023. While Clinic Catalyst is at a pre-seed stage and not directly comparable, this illustrates the enterprise value achievable by becoming a critical workflow system for a large provider base. If the "Vertical SaaS Dominance" scenario plays out, capturing a meaningful share of a high-margin specialty clinic segment could support a valuation in the hundreds of millions of dollars (scenario, not a forecast). The total addressable market for healthcare administration and operational cost reduction is routinely measured in the tens of billions, providing ample room for a scaled winner to emerge [HealthTech Alpha, January 2024].
Single-source, plausible -- Opportunity analysis is based on company claims and founder background; market size and comparable valuation context are inferred from sector dynamics rather than specific, corroborated financials for this company.
Sources
From the public record
[HealthTech Alpha, January 2024] Clinic Catalyst Company Profile: Funding, Investors & Partnerships | https://www.healthtechalpha.com/venture/clinic-catalyst
[cliniccatalyst.com, retrieved 2024] Clinic Catalyst - AI for Healthcare | https://cliniccatalyst.com/
[Crunchbase, May 2025] Pre Seed Round - Clinic Catalyst - Crunchbase Funding Round Profile | https://www.crunchbase.com/funding_round/clinic-catalyst-pre-seed--7d359a61
[F6S, October 2017] Clinic Catalyst | https://www.f6s.com/company/clinic-catalyst
[TechCrunch, June 2021] PharmEasy to acquire majority stake in Thyrocare for $613M | https://techcrunch.com/2021/06/25/indian-healthcare-startup-pharmeasy-to-acquire-majority-stake-in-listed-firm-thyrocare-for-over-600-million/
[Bloomberg, July 2021] Watch India's PharmEasy Aims to Make Drugs More Accessible: Co-Founder - Bloomberg | https://www.bloomberg.com/news/videos/2021-07-09/india-s-pharmeasy-aims-to-make-drugs-more-accessible-co-founder-video
[Bloomberg Markets, retrieved 2026] Siddharth Shah, Api Holdings Pvt Ltd: Profile and Biography - Bloomberg Markets | https://www.bloomberg.com/profile/person/22366473
[Bloomberg Markets, retrieved 2026] Siddharth Shah, Navikenz Inc: Profile and Biography - Bloomberg Markets | https://www.bloomberg.com/profile/person/25100095
[Crunchbase, retrieved 2024] Clinic Catalyst - Financial Details | https://www.crunchbase.com/organization/clinic-catalyst/financial_details
[PERPLEXITY SONAR PRO BRIEF, retrieved 2024] Clinic Catalyst , research brief | https://www.f6s.com/company/clinic-catalyst
Articles about Clinic Catalyst
- Clinic Catalyst Sells the AI Receptionist to the Overwhelmed Clinic — The PharmEasy co-founder's new startup aims to automate patient calls and paperwork, backed by a pre-seed from Forum Ventures.